PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · News & media

New research shows Ozempic may help curb alcohol addiction

News & media5:52Dec 2023

Today’s cheapest semaglutide$39/mo at Wellmedr, sale price.Compare all semaglutide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

This segment covers early research suggesting that semaglutide, the drug used for weight loss, may also reduce drinking in people with alcohol use disorder. Reporter the speaker describes a small case study of six people who screened positive for alcohol use disorder. According to the report, all six saw a clinically significant drop in symptoms while taking semaglutide for weight loss. A woman named Christy Martin, who was not part of the study, says her nightly wine habit has faded and she no longer has any desire to drink. The report notes that larger clinical trials are now being set up.

Published by ABC News on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

In the studio, the channel medical contributor another speaker explains that the study adds to a growing body of anecdotal evidence and case series reports based on patient questionnaires and self-reports. She says some specialists report patients cutting back on shopping, gambling, smoking, and in some cases nicotine or opiate use. One theory she mentions is that these drugs may lessen the dopamine satisfaction people get from drinking or other rewarding behaviors. She says more research is needed and that the unknowns and possible side effects deserve attention.

Another speaker also advises anyone worried about substance use to talk to a trusted person and then a healthcare professional, and she lists medication, counseling, and cognitive behavioral therapy as proven treatments. She cautions against relying on headlines or social media anecdotes, and says these drugs are FDA approved for type 2 diabetes and obesity or certain weight gain. According to her, people should use them under a physician's guidance because long-term safety, efficacy, and dose response for off-label uses are still unclear.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:31 A case study of six people who screened positive for alcohol use disorder found a clinically significant symptom decrease while on semaglutide for weight loss.
  2. 1:03 The reporter says the small study is setting the stage for larger clinical trials of semaglutide as a treatment for alcohol use disorder.
  3. 2:05 Another speaker says the research adds to anecdotal evidence and case series, with some specialists hearing of less shopping, gambling, smoking, and nicotine or opiate use.
  4. 3:06 Another speaker describes one theory that these drugs may dampen the dopamine satisfaction people get from drinking, shopping, or gambling.
  5. 3:36 She says proven treatments exist for substance use disorder, including medication, counseling, and cognitive behavioral therapy, and urges people to seek professional help.
  6. 4:37 She notes the drugs are FDA approved for type 2 diabetes and obesity or certain weight gain, and should be taken under physician guidance because long-term safety for off-label uses is unknown.

Key moments

Tap one to play from there.

  1. 0:02 Alcohol
  2. 3:21 Side effects
  3. 4:25 Wrapping up

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic and semaglutide

Questions this video answers

Can semaglutide help with alcohol use disorder?

According to the video, a case study of six people with alcohol use disorder found a clinically significant decrease in symptoms while they took semaglutide for weight loss. The reporter stresses this was a very small initial study, and larger trials are underway.

How might GLP-1 drugs reduce addictive behaviors?

Another speaker describes one theory that the drugs may lower the satisfaction of the dopamine response people get from drinking, shopping, or gambling. She frames this as a theory and says more research is needed.

Is it safe to use semaglutide off-label for alcohol use?

Another speaker says the medications are FDA approved for type 2 diabetes and obesity or certain weight gain, and should be taken under a physician's guidance. She says there is a lot that is not known about long-term safety, efficacy, and dose response for off-label uses.

What treatments are available for substance use disorder?

Another speaker says proven treatments exist regardless of the substance, including medication, counseling, and cognitive behavioral therapy. She advises talking to a trusted person who can help you reach a healthcare professional.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Semaglutide for weight loss: which version, and what each costs

    Semaglutide is the molecule. For weight loss the FDA-approved version is Wegovy, sold as a weekly pen and a daily tablet. Ozempic is the same molecule approved for type 2 diabetes, so using it for weight is off-label. Compounded semaglutide uses semaglutide as its active ingredient, comes from a compounding pharmacy, is not FDA-approved, and is what most cash buyers actually take because it costs a fraction of the brand. All three produce the same side effects. What differs is the approval, the oversight and the price.

  • GLP-1s for binge eating: what semaglutide, liraglutide and tirzepatide trials show

    No GLP-1 is FDA approved for binge eating disorder; the only approved drug is lisdexamfetamine (Vyvanse). A 2026 meta-analysis of 25 randomized trials reports moderate drops in binge eating on GLP-1s, larger in people diagnosed with the disorder, but rates every trial at high risk or some concerns of bias. The one placebo-controlled liraglutide trial in diagnosed BED showed no significant difference. A tirzepatide versus Vyvanse trial is recruiting.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

Next steps

Ozempic prices

Insurance

Find more like it

Side effectsAlcoholThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV